Benchmarking Surgical Outcomes for Endoscopic Transnasal Craniopharyngioma Resection: Implications for Clinical Practice From the RAPID Consortium

BACKGROUND AND OBJECTIVES: Craniopharyngiomas are complex intracranial tumors that pose significant challenges in surgical management. We aimed to develop risk-stratified surgical outcome benchmarks for adult patients undergoing endoscopic craniopharyngioma resection by using the Registry of Adenomas of the Pituitary and Related Disorders database to facilitate comparisons across institutions and guide clinical decision-making. METHODS: A retrospective cohort of adult patients (18 years and older) with craniopharyngioma undergoing a first-time endoscopic transnasal surgery across 14 academic centers in the United States was analyzed using data collected from 2011 to 2024. Patients were stratified into low-risk and high-risk cohorts based on criteria including age, body mass index, selected tumor characteristics (size, infundibular relationship, intraventricular extension), and previous radiation. Surgical outcomes were analyzed, and benchmarking ranges were defined using the established methodology. RESULTS: The overall cohort included 318 patients with a mean age of 50 years. Upon benchmarking analysis (50th-75th percentile performance), low-risk patients (n = 136) had a median length of stay of 4.0 to 6.0 days, 90-day readmission rates of 15.5% to 22.2%, skilled nursing facility discharge rates of <1.0%, postoperative cerebrospinal fluid leak incidence of <1.0% to 14.3%, gross total resection rates of 50.0% to 60.8%, new postoperative arginine vasopressin deficiency rates of 33.3% to 50.0%, and tumor progression/recurrence rates of <1.0% to 18.3% over a median follow-up period of 27.0 (IQR 10.5-56.5) months. Benchmarking ranges were proposed for each outcome to facilitate cross-institutional comparisons. CONCLUSION: Establishing surgical outcome benchmarks for adult patients undergoing craniopharyngioma resection using data from the Registry of Adenomas of the Pituitary and Related Disorders provides a framework for assessing surgical performance and guiding clinical decision-making. Benchmark ranges can inform institutional quality improvement efforts, perioperative risk stratification, and patient counseling regarding expected postoperative outcomes.

Authors

Institutions

Publication Details

Journal
Operative Neurosurgery
Published
2026-05-13
DOI
https://doi.org/10.1227/ons.0000000000002055
Primary Topic
Pituitary Gland Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Benchmarking Surgical Outcomes for Endoscopic Transnasal Craniopharyngioma Resection: Implications for Clinical Practice From the RAPID Consortium

Donato R. Pacione, Sandhya Rupa Palit, Michael R. Chicoine, Samuel A. Tenhoeve et al.
Operative Neurosurgery
Pituitary Gland Disorders and Treatments
article

Benchmarking Surgical Outcomes for Endoscopic Transnasal Craniopharyngioma Resection: Implications for Clinical Practice From the RAPID Consortium

Donato R. Pacione, Sandhya Rupa Palit, Michael R. Chicoine, Samuel A. Tenhoeve, Daniel M. Prevedello, Michelle Magana Mendoza, Michael P. Catalino, Michael Karsy, Debraj Mukherjee, Georgios A. Zenonos, Jamie Van Gompel, James J. Evans, Nathan T. Zwagerman, William T. Couldwell, Andrew S. Little, Albert H. Kim, Juan C. Fernandez-Miranda, Marvin Bergsneider, Cody Orton, Andre Beer-Furlan, Gabriel Zada, Kyle C. Wu, Adam N. Mamelak, Stephanie K. Cheok, Diwas Gautam, Ramin A. Morshed, Paul A. Gardner, Varun R. Kshettry, Carolina G. Benjamin, Won Kim, Julie M. Silverstein, Robert C. Rennert, Garni Barkhoudarian, Spiros L. Blackburn
article en

Abstract

BACKGROUND AND OBJECTIVES: Craniopharyngiomas are complex intracranial tumors that pose significant challenges in surgical management. We aimed to develop risk-stratified surgical outcome benchmarks for adult patients undergoing endoscopic craniopharyngioma resection by using the Registry of Adenomas of the Pituitary and Related Disorders database to facilitate comparisons across institutions and guide clinical decision-making. METHODS: A retrospective cohort of adult patients (18 years and older) with craniopharyngioma undergoing a first-time endoscopic transnasal surgery across 14 academic centers in the United States was analyzed using data collected from 2011 to 2024. Patients were stratified into low-risk and high-risk cohorts based on criteria including age, body mass index, selected tumor characteristics (size, infundibular relationship, intraventricular extension), and previous radiation. Surgical outcomes were analyzed, and benchmarking ranges were defined using the established methodology. RESULTS: The overall cohort included 318 patients with a mean age of 50 years. Upon benchmarking analysis (50th-75th percentile performance), low-risk patients (n = 136) had a median length of stay of 4.0 to 6.0 days, 90-day readmission rates of 15.5% to 22.2%, skilled nursing facility discharge rates of <1.0%, postoperative cerebrospinal fluid leak incidence of <1.0% to 14.3%, gross total resection rates of 50.0% to 60.8%, new postoperative arginine vasopressin deficiency rates of 33.3% to 50.0%, and tumor progression/recurrence rates of <1.0% to 18.3% over a median follow-up period of 27.0 (IQR 10.5-56.5) months. Benchmarking ranges were proposed for each outcome to facilitate cross-institutional comparisons. CONCLUSION: Establishing surgical outcome benchmarks for adult patients undergoing craniopharyngioma resection using data from the Registry of Adenomas of the Pituitary and Related Disorders provides a framework for assessing surgical performance and guiding clinical decision-making. Benchmark ranges can inform institutional quality improvement efforts, perioperative risk stratification, and patient counseling regarding expected postoperative outcomes.

Operative Neurosurgery
University of Southern California (US), Cedars-Sinai Medical Center (US), Cleveland Clinic (US), St. Joseph's Hospital and Medical Center (US), Mayo Clinic (US), Johns Hopkins University (US), University of Miami (US), Thomas Jefferson University (US), University of California, Los Angeles (US), University of California, San Francisco (US), Medical College of Wisconsin (US), Washington University in St. Louis (US), University of Utah (US), University of Michigan (US), The Ohio State University Wexner Medical Center (US), Moffitt Cancer Center (US), Saint John's Health Center (US), University of Pittsburgh Medical Center (US), Neurological Surgery (US), University of Houston (US), University of Virginia (US), New York University (US), University of Missouri (US), The University of Texas Health Science Center at Houston (US), Stanford University (US)
Foundation for Barnes-Jewish Hospital, Barrow Neurological Foundation
Peace, Justice and strong institutions
Openalex Percentile: Top 6%
Pituitary Gland Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.